Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wided Najahi-Missaoui

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Blood|April 16, 2005
Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatasesWided Najahi-Missaoui, Harry A Dailey
International Journal of Molecular Sciences|September 28, 2023
Lyophilization of Nanoparticles, Does It Really Work? Overview of the Current Status and ChallengesMatthew S Gatto, Wided Najahi-Missaoui
International Journal of Molecular Sciences|April 13, 2023
Liposomes in Cancer Therapy: How Did We Start and Where Are We NowMelody D Fulton, Wided Najahi-Missaoui
International Journal of Molecular Sciences|January 5, 2021
Safe Nanoparticles: Are We There Yet?Wided Najahi-Missaoui, Robert D Arnold, Brian S Cummings
Life (Basel, Switzerland)|June 27, 2024
Targeted Liposomal Drug Delivery: Overview of the Current Applications and ChallengesMatthew S Gatto, McNeely P Johnson, Wided Najahi-Missaoui
International Journal of Molecular Sciences|December 16, 2020
Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A<sub>2</sub> (sPLA<sub>2</sub>) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer CellsWided Najahi-Missaoui, Nhat D Quach, Payaningal R Somanath, et al.
Oncology Letters|September 16, 2020
Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A<sub>2</sub> suppress prostate cancer growth and metastasisArti Verma, Wided Najahi-Missaoui, Brian S Cummings, et al.
Pharmacology Research & Perspectives|September 14, 2019
Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasionWided Najahi-Missaoui, Nhat D Quach, Amber Jenkins, et al.
The Biochemical Journal|August 17, 2021
Insight into the function of active site residues in the catalytic mechanism of human ferrochelataseAmy E Medlock, Wided Najahi-Missaoui, Mesafint T Shiferaw, et al.
Biochemistry|June 15, 2007
Altered orientation of active site residues in variants of human ferrochelatase. Evidence for a hydrogen bond network involved in catalysisHarry A Dailey, Chia-Kuei Wu, Peter Horanyi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood|April 16, 2005
Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatasesWided Najahi-Missaoui, Harry A Dailey
International Journal of Molecular Sciences|September 28, 2023
Lyophilization of Nanoparticles, Does It Really Work? Overview of the Current Status and ChallengesMatthew S Gatto, Wided Najahi-Missaoui
International Journal of Molecular Sciences|April 13, 2023
Liposomes in Cancer Therapy: How Did We Start and Where Are We NowMelody D Fulton, Wided Najahi-Missaoui
International Journal of Molecular Sciences|January 5, 2021
Safe Nanoparticles: Are We There Yet?Wided Najahi-Missaoui, Robert D Arnold, Brian S Cummings
Life (Basel, Switzerland)|June 27, 2024
Targeted Liposomal Drug Delivery: Overview of the Current Applications and ChallengesMatthew S Gatto, McNeely P Johnson, Wided Najahi-Missaoui
International Journal of Molecular Sciences|December 16, 2020
Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A<sub>2</sub> (sPLA<sub>2</sub>) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer CellsWided Najahi-Missaoui, Nhat D Quach, Payaningal R Somanath, et al.
Oncology Letters|September 16, 2020
Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A<sub>2</sub> suppress prostate cancer growth and metastasisArti Verma, Wided Najahi-Missaoui, Brian S Cummings, et al.
Pharmacology Research & Perspectives|September 14, 2019
Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasionWided Najahi-Missaoui, Nhat D Quach, Amber Jenkins, et al.
The Biochemical Journal|August 17, 2021
Insight into the function of active site residues in the catalytic mechanism of human ferrochelataseAmy E Medlock, Wided Najahi-Missaoui, Mesafint T Shiferaw, et al.
Biochemistry|June 15, 2007
Altered orientation of active site residues in variants of human ferrochelatase. Evidence for a hydrogen bond network involved in catalysisHarry A Dailey, Chia-Kuei Wu, Peter Horanyi, et al.
Pageof 2